QQQ   423.56 (-0.54%)
AAPL   166.87 (-0.67%)
MSFT   406.17 (-1.38%)
META   503.81 (+1.95%)
GOOGL   156.66 (+0.77%)
AMZN   179.10 (-1.20%)
TSLA   149.73 (-3.68%)
NVDA   846.02 (+0.67%)
AMD   153.89 (-0.08%)
NIO   3.99 (+2.05%)
BABA   68.84 (+0.03%)
T   16.22 (+0.62%)
F   12.00 (-0.33%)
MU   113.05 (-2.82%)
GE   154.16 (-0.97%)
CGC   7.87 (+21.26%)
DIS   112.74 (-0.18%)
AMC   2.90 (-2.68%)
PFE   25.29 (-0.51%)
PYPL   62.12 (-1.80%)
XOM   118.13 (-0.42%)
QQQ   423.56 (-0.54%)
AAPL   166.87 (-0.67%)
MSFT   406.17 (-1.38%)
META   503.81 (+1.95%)
GOOGL   156.66 (+0.77%)
AMZN   179.10 (-1.20%)
TSLA   149.73 (-3.68%)
NVDA   846.02 (+0.67%)
AMD   153.89 (-0.08%)
NIO   3.99 (+2.05%)
BABA   68.84 (+0.03%)
T   16.22 (+0.62%)
F   12.00 (-0.33%)
MU   113.05 (-2.82%)
GE   154.16 (-0.97%)
CGC   7.87 (+21.26%)
DIS   112.74 (-0.18%)
AMC   2.90 (-2.68%)
PFE   25.29 (-0.51%)
PYPL   62.12 (-1.80%)
XOM   118.13 (-0.42%)
QQQ   423.56 (-0.54%)
AAPL   166.87 (-0.67%)
MSFT   406.17 (-1.38%)
META   503.81 (+1.95%)
GOOGL   156.66 (+0.77%)
AMZN   179.10 (-1.20%)
TSLA   149.73 (-3.68%)
NVDA   846.02 (+0.67%)
AMD   153.89 (-0.08%)
NIO   3.99 (+2.05%)
BABA   68.84 (+0.03%)
T   16.22 (+0.62%)
F   12.00 (-0.33%)
MU   113.05 (-2.82%)
GE   154.16 (-0.97%)
CGC   7.87 (+21.26%)
DIS   112.74 (-0.18%)
AMC   2.90 (-2.68%)
PFE   25.29 (-0.51%)
PYPL   62.12 (-1.80%)
XOM   118.13 (-0.42%)
QQQ   423.56 (-0.54%)
AAPL   166.87 (-0.67%)
MSFT   406.17 (-1.38%)
META   503.81 (+1.95%)
GOOGL   156.66 (+0.77%)
AMZN   179.10 (-1.20%)
TSLA   149.73 (-3.68%)
NVDA   846.02 (+0.67%)
AMD   153.89 (-0.08%)
NIO   3.99 (+2.05%)
BABA   68.84 (+0.03%)
T   16.22 (+0.62%)
F   12.00 (-0.33%)
MU   113.05 (-2.82%)
GE   154.16 (-0.97%)
CGC   7.87 (+21.26%)
DIS   112.74 (-0.18%)
AMC   2.90 (-2.68%)
PFE   25.29 (-0.51%)
PYPL   62.12 (-1.80%)
XOM   118.13 (-0.42%)

Rock Creek Pharmaceuticals (RCPIQ) Short Interest Ratio & Short Volume

Rock Creek Pharmaceuticals Short Interest Data

Current Short Volume
6,400 shares
Previous Short Volume
6,800 shares
Change Vs. Previous Month
-5.88%
Dollar Volume Sold Short
$0.00
Short Interest Ratio / Days to Cover
0.2
Last Record Date
January 31, 2023
Today's Trading Volume
0 shares
Average Trading Volume
0 shares
Today's Volume Vs. Average
NaN
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Rock Creek Pharmaceuticals ?

Sign up to receive the latest short interest report for Rock Creek Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

RCPIQ Short Interest Over Time

RCPIQ Days to Cover Over Time

RCPIQ Percentage of Float Shorted Over Time

Rock Creek Pharmaceuticals Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
1/31/20236,400 shares $0.00 -5.9%N/A0.2 $0.00
1/15/20236,800 shares $0.00 No ChangeN/A0.6 $0.00
12/30/20226,800 shares $0.68 -1.5%N/A0.1 $0.00
12/15/20226,900 shares $0.00 No ChangeN/A69 $0.00
11/30/20226,900 shares $0.00 No ChangeN/A13.8 $0.00
11/15/20226,900 shares $0.00 No ChangeN/A69 $0.00
10/31/20226,900 shares $0.00 No ChangeN/A2.5 $0.00
10/15/20226,900 shares $0.00 No ChangeN/A34.5 $0.00
9/30/20226,900 shares $0.00 No ChangeN/A34.5 $0.00
9/15/20226,900 shares $0.00 No ChangeN/A69 $0.00
8/31/20226,900 shares $0.00 No ChangeN/A69 $0.00
8/15/20226,900 shares $0.00 No ChangeN/A7.7 $0.00
7/31/20226,900 shares $0.00 No ChangeN/A69 $0.00
7/15/20226,900 shares $0.00 -85.4%N/A0.9 $0.00
6/30/202247,200 shares $0.00 No ChangeN/A472 $0.00
6/15/202247,200 shares $0.00 No ChangeN/A94.4 $0.00
5/31/202247,200 shares $0.00 No ChangeN/A472 $0.00
5/15/202247,200 shares $0.00 No ChangeN/A472 $0.00
4/30/202247,200 shares $0.00 No ChangeN/A118 $0.00
4/15/202247,200 shares $0.00 No ChangeN/A4.3 $0.00
3/31/202247,200 shares $0.00 No ChangeN/A33.7 $0.00
3/15/202247,200 shares $0.00 +23,500.0%N/A118 $0.00
2/28/2022200 shares $0.02 No ChangeN/A0 $0.00
2/15/2022200 shares $0.00 No ChangeN/A2 $0.00
1/31/2022200 shares $0.02 No ChangeN/A2 $0.00
1/15/2022200 shares $0.00 No ChangeN/A2 $0.00
12/31/2021200 shares $0.00 No ChangeN/A0 $0.00
12/15/2021200 shares $0.00 No ChangeN/A1 $0.00
11/30/2021200 shares $0.00 No ChangeN/A2 $0.00
11/15/2021200 shares $0.00 No ChangeN/A2 $0.00
10/29/2021200 shares $0.00 No ChangeN/A0 $0.00
10/15/2021200 shares $0.00 No ChangeN/A1 $0.00
9/30/2021200 shares $0.14 No ChangeN/A0 $0.00
9/15/2021200 shares $0.14 -96.1%N/A0 $0.00
8/31/20215,100 shares $4.59 +142.9%N/A0 $0.00
8/13/20212,100 shares $3.78 +950.0%N/A0 $0.00
7/30/2021200 shares $0.20 No ChangeN/A0 $0.00
7/15/2021200 shares $0.32 -93.8%N/A0 $0.00
6/30/20213,200 shares $7.36 -79.6%N/A0 $0.00
6/15/202115,700 shares $39.25 +201.9%N/A0 $0.00
The “Perfect Storm” for Gold (Ad)

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

Click here now to download the free Precious Metals Buying Guide!

RCPIQ Short Interest - Frequently Asked Questions

What is Rock Creek Pharmaceuticals' current short interest?

Short interest is the volume of Rock Creek Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of January 31st, traders have sold 6,400 shares of RCPIQ short. Learn More on Rock Creek Pharmaceuticals' current short interest.

Is Rock Creek Pharmaceuticals' short interest increasing or decreasing?

Rock Creek Pharmaceuticals saw a decline in short interest in January. As of January 31st, there was short interest totaling 6,400 shares, a decline of 5.9% from the previous total of 6,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Rock Creek Pharmaceuticals' short interest compare to its competitors?

Here is how the short interest of companies in the sector of "medical" compare to Rock Creek Pharmaceuticals: SNDL Inc. (3.98%), Abliva AB (publ) (0.00%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Occidental Petroleum Co. ($3.19 billion), Snowflake Inc. ($2.35 billion), T. Rowe Price Group, Inc. ($2.14 billion), Coinbase Global, Inc. ($2.14 billion), Paramount Global ($1.99 billion), Etsy, Inc. ($1.76 billion), Lucid Group, Inc. ($1.70 billion), Wayfair Inc. ($1.63 billion), Old Dominion Freight Line, Inc. ($1.61 billion), and CarMax, Inc. ($1.60 billion). View all of the most shorted stocks.

What does it mean to sell short Rock Creek Pharmaceuticals stock?

Short selling RCPIQ is an investing strategy that aims to generate trading profit from Rock Creek Pharmaceuticals as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Rock Creek Pharmaceuticals?

A short squeeze for Rock Creek Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of RCPIQ, which in turn drives the price of the stock up even further.

How often is Rock Creek Pharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RCPIQ, twice per month. The most recent reporting period available is January, 31 2023.



More Short Interest Resources from MarketBeat

This page (OTCMKTS:RCPIQ) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners